Skip to main content
Equibles

Baird Financial Group, Inc.

Position in BRNS — Barinthus Biotherapeutics plc.

CIK 1648711 MILWAUKEE, WI
Back to BRNS Full portfolio

Position in BRNS

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$69,934
+$9,643 QoQ
Shares Held
105,961
0.0% QoQ
Ownership
0.259%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 15 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BRNS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Baird Financial Group, Inc. holds $226,318,173 across 30 Biotechnology names. BRNS ranks #29 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 368,978 $105,147,660
2 REGN
Regeneron Pharmaceuticals, Inc.
 52,845 $32,950,970
3 INCY
Incyte Corp
 224,855 $25,489,561
4 EXEL
Exelixis, Inc.
 437,138 $23,784,676
5 INVA
Innoviva, Inc.
 274,391 $6,231,419
6 TWST
Twist Bioscience Corp
 49,862 $5,129,802
7 BBIO
BridgeBio Pharma, Inc.
 38,672 $2,880,290
8 ASND
Ascendis Pharma A/S
 10,735 $2,863,239

All Filings in BRNS

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $69,934 105,961
2026-03-31 $60,291 105,961
2025-12-31 $74,172 105,961
2025-09-30 $134,326 107,461
2025-06-30 $178,988 192,461
2025-03-31 $89,964 92,461
2024-12-31 $111,692 92,461
2024-09-30 $110,028 92,461
2024-06-30 $374,787 267,705
2024-03-31 $399,137 167,705
2023-12-31 $724,332 196,296
2023-09-30 $606,554 196,296
2023-06-30 $404,369 196,296
2023-03-31 $401,623 179,296
2022-12-31 $217,283 92,461